Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

University of Occupational and Environmental Health and Yakult Honsha disclose ZNF143 inhibitors

Aug. 3, 2016

Novartis patents angiotensin receptor antagonists

Aug. 3, 2016

University of California, Oakland describes heat schock protein inhibitors

Aug. 2, 2016

Janssen Pharmaceutica introduces cannabinoid CB1 inverse agonists

Aug. 2, 2016

Korea Research Institute of Bioscience and Biotechnology discloses antibiotic compounds

Aug. 2, 2016

Bayer Healthcare patents chemokine receptor antagonists

Aug. 2, 2016

The Vanderbilt University reports mGlu4 receptor PAMs

Aug. 2, 2016

Chengdu Bestchiralbio introduces LDL-receptor expression enhancers

Aug. 1, 2016

Merck & Co. discloses BTK inhibitors

Aug. 1, 2016

Constellation Pharmaceuticals and Genentech report demethylase 2B inhibitors

Aug. 1, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...